Canopy Growth (CGC) Other Operating Expenses (2019 - 2026)
Canopy Growth (CGC) posted Other Operating Expenses of -$4.0 million for Q4 2025, down 1026.3% sequentially from -$358957.7 in Q3 2025, and down 339.51% YoY from $1.7 million in Q4 2024.
Canopy Growth (CGC) Other Operating Expenses (2019 - 2026) Analysis & Trends
Canopy Growth has reported Other Operating Expenses for 7 years, with the latest figure at -$4.0 million in Q4 2025.
- Quarterly Other Operating Expenses fell 339.51% year-over-year to -$4.0 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$6.3 million (up 61.02% YoY) and the FY2026 annual result came in at -$48.9 million, down 124.72% from the prior year.
- Other Operating Expenses retreated to -$4.0 million in Q4 2025 per CGC's latest filing, from -$358957.7 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $22.3 million in Q3 2023 and troughed at -$1.3 billion in Q3 2022.
- A 5-year average of -$87.0 million and a median of -$919866.1 in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2023 and 2025: Other Operating Expenses soared 101.68% in 2023, then slumped 12993.95% in 2025.
- Over 5 years, Other Operating Expenses stood at $5.4 million in 2021, then tumbled by 405.0% to -$16.4 million in 2022, then tumbled by 36.23% to -$22.3 million in 2023, then jumped by 95.88% to -$919866.1 in 2024, then slumped by 339.51% to -$4.0 million in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$4.0 million, -$358957.7, and -$1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Canopy Growth | 431.13 Mn | 184.12 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.00 Mn |
| Dec 31, 2025 | -4.04 Mn |
| Sep 30, 2025 | -358,957.69 |
| Jun 30, 2025 | -1.91 Mn |
| Dec 31, 2024 | -919,866.15 |
| Sep 30, 2024 | -15.27 Mn |
| Jun 30, 2024 | -14,622.81 |
| Mar 31, 2024 | -47.15 Mn |
| Dec 31, 2023 | -22.34 Mn |
| Sep 30, 2023 | 22.30 Mn |
| Jun 30, 2023 | -1.44 Mn |
| Mar 31, 2023 | -299.53 Mn |
| Dec 31, 2022 | -16.40 Mn |
| Sep 30, 2022 | -1.32 Bn |
| Jun 30, 2022 | 6.32 Mn |
| Mar 31, 2022 | 8.55 Mn |
| Dec 31, 2021 | 5.38 Mn |
| Sep 30, 2021 | 12.67 Mn |
| Jun 30, 2021 | 10.68 Mn |
| Mar 31, 2021 | 15.42 Mn |